An implantable guide-screw system for brain tumor studies in small animals
- PMID: 10659021
- DOI: 10.3171/jns.2000.92.2.0326
An implantable guide-screw system for brain tumor studies in small animals
Abstract
Object: To overcome the problems associated with using stereotactic techniques to establish intracranial xenografts in nude mice and to treat engrafted tumors with intratumoral therapies (such as gene or viral therapies), the authors developed an implantable guide-screw system. In this study, they describe the guide-screw system, its method of implantation, and their experience with establishing xenografts and delivering intratumoral therapy.
Methods: The system consists of a 2.6-mm guide screw with a central 0.5-mm diameter hole that accepts the 26-gauge needle of a Hamilton syringe. The screw is implanted into a small drill hole made 2.5 mm lateral and 1 mm anterior to the bregma. A stylet is used to cap the screw between treatments. Tumor cells or therapeutic agents are injected in a freehand fashion by using a Hamilton syringe and a 26-gauge needle fitted with a cuff to determine the depth of injection. To test this system, guide screws were successfully implanted in 44 (98%) of 45 nude mice. After 1 to 2 weeks of recovery, 38 mice were inoculated with U87MG cells and killed 5 days later. On histological studies in 37 (97%) of these animals, xenografts were evident within the caudate nucleus (mean diameter 2.5 mm). To determine whether injections into the center of an established xenograft could be reproducibly achieved with the guide-screw system, an adenovirus vector containing the beta-galactosidase gene was injected 3 days after cell implantation in 15 of the mice. All of these animals demonstrated transduced cells within the tumor. To demonstrate that engrafted animals have a uniform survival time that is indicative of reproducible tumor growth, the survival of six mice was assessed after engraftment with U87MG cells. All six animals died within 28 to 35 days.
Conclusions: The guide-screw system allows a large number of animals to be rapidly and reproducibly engrafted and for intratumoral treatments to be accurately delivered into established xenografts.
Similar articles
-
Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System.PLoS One. 2017 Jan 20;12(1):e0170501. doi: 10.1371/journal.pone.0170501. eCollection 2017. PLoS One. 2017. PMID: 28107439 Free PMC article.
-
Improved method for the intracerebral engraftment of tumour cells and intratumoural treatment using a guide screw system in mice.Acta Neurochir (Wien). 2003 Sep;145(9):777-81; discussion 781. doi: 10.1007/s00701-003-0091-5. Acta Neurochir (Wien). 2003. PMID: 14505105
-
A method to accurately inject tumor cells into the caudate/putamen nuclei of the mouse brain.Tokai J Exp Clin Med. 2004 Dec;29(4):167-73. Tokai J Exp Clin Med. 2004. PMID: 15717488
-
A simple guide screw method for intracranial xenograft studies in mice.J Vis Exp. 2011 Sep 26;(55):3157. doi: 10.3791/3157. J Vis Exp. 2011. PMID: 21968439 Free PMC article.
-
In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.Cancer Res. 1993 Jan 1;53(1):83-8. Cancer Res. 1993. PMID: 8380127
Cited by
-
REST regulates oncogenic properties of glioblastoma stem cells.Stem Cells. 2012 Mar;30(3):405-14. doi: 10.1002/stem.1020. Stem Cells. 2012. PMID: 22228704 Free PMC article.
-
An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.Neuro Oncol. 2021 Nov 2;23(11):1911-1921. doi: 10.1093/neuonc/noab128. Neuro Oncol. 2021. PMID: 34059921 Free PMC article.
-
Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.Neoplasia. 2005 Jan;7(1):48-56. doi: 10.1593/neo.04391. Neoplasia. 2005. PMID: 15720816 Free PMC article.
-
Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy.Neuro Oncol. 2011 Jul;13(7):748-58. doi: 10.1093/neuonc/nor037. Epub 2011 Jun 8. Neuro Oncol. 2011. PMID: 21653596 Free PMC article.
-
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.Neuro Oncol. 2011 Aug;13(8):894-903. doi: 10.1093/neuonc/nor049. Epub 2011 Jun 8. Neuro Oncol. 2011. PMID: 21653597 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous